Mobia Medical Vivistim Assigned to Apc 1580 - Jul 2

The Story

CMS has proposed to maintain CPT4 Code 64568, the procedure code used for the Vivistimae procedure, under New Technology APC 1580 in its proposed 2027 Hospital Outpatient Prospective Payment System rule, Mobia Medical announced. The clarification keeps the Vivistim procedure on the New Technology pathway and reduces immediate reimbursement uncertainty for $MOBI.

Why It Matters For Your Portfolio

• Reimbursement Continuity: Keeping CPT 64568 in New Technology APC 1580 preserves the hospital outpatient billing route, which supports utilization and revenue forecasts for Mobia and reduces a major regulatory risk.
• Valuation Inputs: Analysts and modelers can use multiple scenario inputs including 16.17%, 7.78%, and 0.53% when stress-testing growth, adoption, and margin assumptions for $MOBI.
• Clinical Adoption: Lower reimbursement uncertainty may improve hospital willingness to adopt the Vivistim procedure, which can affect procedure volumes and top-line projections.
• Reduced Near-Term Binary Risk: Confirmation in the proposed rule limits a near-term downside catalyst tied to coding reassignment, helping stabilize investor expectations around commercial execution.

The Trade

Healthcare growth investors and allocators tracking medtech reimbursement should take note, while short-term traders may watch for market reaction to the CMS final rule. What to watch next: the CMS final 2027 HOPPS rule, hospital coding guidance, and any updates from Mobia on commercial uptake.